Objective The authors evaluated the efficacy and safety of lurasidone in the treatment of
patients with major depressive episodes associated with bipolar I disorder. Method Patients …

Objective Few studies have been reported that support the efficacy of adjunctive therapy for
patients with bipolar I depression who have had an insufficient response to monotherapy …

Objective To evaluate the efficacy and safety of lurasidone in children and adolescents with
bipolar depression. Method Patients 10 to 17 years old with a DSM-5 diagnosis of bipolar I …

Objective: Accumulating evidence indicates that manic symptoms below the threshold for
hypomania (mixed features) are common in individuals with major depressive disorder. This …

Objective: Mixed (subsyndromal hypomanic) features are prevalent in patients with bipolar
depression and are associated with more severe and complex illness, including increased …

Rationale There is an unmet need in the treatment of schizophrenia for effective medications
with fewer adverse effects. Objective This study aims to evaluate the efficacy and safety of …

Despite the availability of established antipsychotic agents for the treatment of
schizophrenia, continued unmet needs exist for effective medications with lower adverse …

Method: Patients who completed a 6-week, double-blind, placebo-controlled study
evaluating the efficacy of fixed doses of once-daily lurasidone (40 or 120 mg) or olanzapine …

The aim of this study is to evaluate the long-term safety and tolerability of lurasidone in the
treatment of schizophrenia. Clinically stable adult outpatients with schizophrenia were …

OBJECTIVE: This study was designed to evaluate the short-term efficacy and safety of once-
daily lurasidone (80mg/day and 160mg/day) in the treatment of an acute exacerbation of …